MyFinsight
Home
About
Contact
axsm: the balance sheet
Income Statement
|
Cash Flow
|
Balance Sheet
For the quarter ending 2025-09-30, AXSM has $669,250K in assets.
Balance Sheets Overview
00
No enough data to generate the overview
Buy me a coffee
Page 1
Unit: Thousand (K) dollars (except for numbers of shares and EPS)
Quarterly
123
Balance Sheets
2025-09-30
2025-06-30
Total assets
669,250
639,785
Total stockholders equity
73,727
73,075
Total liabilities and stockholders equity
669,250
639,785
Unit: Thousand (K) dollars (except for numbers of shares and EPS)
Page 1
Buy me a coffee
Time Plot
Show the time plot by selecting a row from the table.
Balance Sheets
Prepaid and other
current assets
$19,789K
Inventories, net
$23,774K
Accounts receivable, net
$196,507K
Cash and cash
equivalents
$325,272K
Non-current inventory and
other assets
$27,481K
Intangible asset, net
$42,126K
Goodwill
$12,042K
Right-of-use asset -
operating lease
$21,654K
Equipment, net
$605K
Total current assets
$565,342K
Total assets
$669,250K
Total liabilities and
stockholders equity
$669,250K
Total stockholders
equity
$73,727K
Total liabilities
$595,523K
Accumulated deficit
-$1,277,402K
Additional paid-in capital
$1,351,124K
Finance lease
liability, long-term
$4,680K
Operating lease
liability, long-term
$23,041K
Loan payable,
long-term
$117,642K
Contingent consideration,
non-current
$89,870K
Total current
liabilities
$360,290K
Common stock, 0.0001
par value per share...
$5K
Short-term borrowings
$70,000K
Contingent consideration,
current
$9,695K
Operating lease
liability, current portion
$736K
Accrued expenses and
other current...
$225,632K
Accounts payable
$54,227K
Subscribe for Financial Insights
Axsome Therapeutics, Inc. (AXSM)
Axsome Therapeutics, Inc. (AXSM)